Notable Labs Return on Investment 2013-2024 | NTBLQ
Current and historical return on investment (ROI) values for Notable Labs (NTBLQ) over the last 10 years.
| Notable Labs ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-06-30 |
$-0.02B |
$0.01B |
-176.47% |
| 2024-03-31 |
$-0.01B |
$0.01B |
-192.59% |
| 2023-12-31 |
$-0.02B |
$0.02B |
-400.00% |
| 2023-09-30 |
$0.01B |
|
inf% |
| 2023-06-30 |
$-0.00B |
|
inf% |
| 2023-03-31 |
$-0.01B |
|
inf% |
| 2022-12-31 |
$-0.01B |
|
inf% |
| 2022-09-30 |
$-0.04B |
|
inf% |
| 2022-06-30 |
$-0.04B |
|
inf% |
| 2022-03-31 |
$-0.04B |
|
inf% |
| 2021-12-31 |
$-0.03B |
|
inf% |
| 2021-09-30 |
$-0.03B |
|
inf% |
| 2021-06-30 |
$-0.03B |
|
inf% |
| 2021-03-31 |
$-0.03B |
|
inf% |
| 2020-12-31 |
$-0.03B |
|
inf% |
| 2020-09-30 |
$-0.02B |
|
-266.67% |
| 2020-06-30 |
$-0.02B |
|
-255.56% |
| 2020-03-31 |
$-0.02B |
|
-244.44% |
| 2019-12-31 |
$-0.02B |
$0.04B |
-222.22% |
| 2019-09-30 |
$-0.02B |
|
inf% |
| 2019-06-30 |
$-0.02B |
|
inf% |
| 2019-03-31 |
$-0.02B |
|
inf% |
| 2018-12-31 |
$-0.02B |
|
inf% |
| 2018-09-30 |
$-0.03B |
|
inf% |
| 2018-06-30 |
$-0.03B |
|
inf% |
| 2018-03-31 |
$-0.03B |
|
inf% |
| 2017-12-31 |
$-0.02B |
|
inf% |
| 2017-09-30 |
$-0.02B |
|
inf% |
| 2017-06-30 |
$-0.02B |
|
inf% |
| 2017-03-31 |
$-0.02B |
|
inf% |
| 2016-12-31 |
$-0.02B |
|
inf% |
| 2016-09-30 |
$-0.01B |
|
inf% |
| 2016-06-30 |
$-0.02B |
|
inf% |
| 2016-03-31 |
$-0.02B |
|
inf% |
| 2015-12-31 |
$-0.02B |
|
inf% |
| 2015-09-30 |
$-0.02B |
|
inf% |
| 2015-06-30 |
$-0.01B |
|
inf% |
| 2015-03-31 |
$-0.01B |
|
inf% |
| 2014-12-31 |
$-0.01B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
